These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 37906801)
1. [Clinical phenotypes of multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19]. Alvarado-Gamarra G; Del Aguila O; Dominguez-Rojas J; Chonlon-Murillo K; Atamari-Anahui N; Borcic A; Sánchez S; Huamani-Echaccaya P; Garcés-Ghilardi R; Estupiftan-Vigil M Andes Pediatr; 2022 Dec; 93(6):841-850. PubMed ID: 37906801 [TBL] [Abstract][Full Text] [Related]
2. Similarities and differences between multiple inflammatory syndrome in children associated with COVID-19 and Kawasaki disease: clinical presentations, diagnosis, and treatment. Zhang QY; Xu BW; Du JB World J Pediatr; 2021 Aug; 17(4):335-340. PubMed ID: 34013488 [TBL] [Abstract][Full Text] [Related]
3. Distinguishing Multisystem Inflammatory Syndrome in Children From COVID-19, Kawasaki Disease and Toxic Shock Syndrome. Godfred-Cato S; Abrams JY; Balachandran N; Jaggi P; Jones K; Rostad CA; Lu AT; Fan L; Jabbar A; Anderson EJ; Kao CM; Hunstad DA; Rosenberg RB; Zafferani MJ; Ede KC; Ballan W; Laham FR; Beltran Y; Bryant B; Meng L; Hammett TA; Oster ME; Bamrah Morris S; Belay ED Pediatr Infect Dis J; 2022 Apr; 41(4):315-323. PubMed ID: 35093995 [TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2-associated multisystem inflammatory syndrome in children: clinical manifestations and the role of infliximab treatment. Abdel-Haq N; Asmar BI; Deza Leon MP; McGrath EJ; Arora HS; Cashen K; Tilford B; Charaf Eddine A; Sethuraman U; Ang JY Eur J Pediatr; 2021 May; 180(5):1581-1591. PubMed ID: 33452570 [TBL] [Abstract][Full Text] [Related]
5. Multisystem inflammatory syndrome (MIS-C) in Pakistani children: A description of the phenotypes and comparison with historical cohorts of children with Kawasaki disease and myocarditis. Mohsin SS; Abbas Q; Chowdhary D; Khalid F; Sheikh AS; Ali Khan ZG; Aslam N; Bhatti OA; Inam M; Saleem AF; Bhutta AT PLoS One; 2021; 16(6):e0253625. PubMed ID: 34153080 [TBL] [Abstract][Full Text] [Related]
6. [Cross-sectional study of the clinical characteristics and outcomes of children hospitalized with COVID-19 in Lima, Peru]. Domínguez Rojas J; Estupiñan Vigil M; Garcés-Ghilardi R; Alvarado-Gamarra G; Del Águila O; Lope Tenorio AF; Ayón Dejo CC; Chonlon Murillo K; Boluarte Baca S; Stapleton Herbozo A; Seminario Aliaga R; Reyes Florian G; Dávila Riega D; Fernández Suárez S; Coronado Muñoz Á Medwave; 2021 Jan; 21(1):e8107. PubMed ID: 33617519 [TBL] [Abstract][Full Text] [Related]
7. Coronavirus disease 2019 (COVID-19): A systematic review of 133 Children that presented with Kawasaki-like multisystem inflammatory syndrome. Keshavarz P; Yazdanpanah F; Azhdari S; Kavandi H; Nikeghbal P; Bazyar A; Rafiee F; Nejati SF; Sadabad FE; Rezaei N J Med Virol; 2021 Sep; 93(9):5458-5473. PubMed ID: 33969513 [TBL] [Abstract][Full Text] [Related]
8. COVID-19 associated multisystemic inflammatory syndrome in 614 children with and without overlap with Kawasaki disease-Turk MIS-C study group. Yilmaz Ciftdogan D; Ekemen Keles Y; Cetin BS; Dalgic Karabulut N; Emiroglu M; Bagci Z; Buyukcam A; Erdeniz EH; Arga G; Yesil E; Cakici O; Karbuz A; Sahbudak Bal Z; Kara SS; Ozer A; Metin Akcan O; Elmas Bozdemir S; Anil AB; Uygun H; Kilic O; Hancerli Torun S; Umit Z; Sutcu M; Ozgokce Ozmen B; Karaoglu Asrak H; Alkan G; Kara Aksay A; Ugur C; Birbilen AZ; Bursal Duramaz B; Akyuz Ozkan E; Burakay O; Yildirim Arslan S; Karadag Oncel E; Celik SF; Kilic AO; Ozen S; Sarikaya R; Demirkol D; Arslan G; Turel O; Sert A; Sari E; Orbak Z; Sahin IO; Varan C; Akturk H; Tuter Oz SK; Durak F; Oflaz MB; Kara M; Karpuz D; Talip Petmezci M; Hatipoglu N; Oncel S; Turgut M; Elmali F; Somer A; Kuyucu N; Dinleyici EC; Kurugöl Z; Ciftci E; Kara A Eur J Pediatr; 2022 May; 181(5):2031-2043. PubMed ID: 35129668 [TBL] [Abstract][Full Text] [Related]
9. Convergence and divergence in Kawasaki disease and multisystem inflammatory syndrome in children: results from the COVASAKI survey. Mastrolia MV; Martini M; Memmini G; Ferrara G; Bernardini R; Peroni D; Consolini R; Marrani E; Agostiniani R; Maccora I; Falorni S; Azzari C; Calabri GB; Pagnini I; Indolfi G; L'Erario M; Trapani S; Simonini G Clin Exp Rheumatol; 2024 Apr; 42(4):931-936. PubMed ID: 38683206 [TBL] [Abstract][Full Text] [Related]
10. Obesity and Outcomes of Kawasaki Disease and COVID-19-Related Multisystem Inflammatory Syndrome in Children. Khoury M; Harahsheh AS; Raghuveer G; Dahdah N; Lee S; Fabi M; Selamet Tierney ES; Portman MA; Choueiter NF; Elias M; Thacker D; Dallaire F; Orr WB; Harris TH; Norozi K; Truong DT; Khare M; Szmuszkovicz JR; Pagano JJ; Manlhiot C; Farid P; McCrindle BW; JAMA Netw Open; 2023 Dec; 6(12):e2346829. PubMed ID: 38064213 [TBL] [Abstract][Full Text] [Related]
11. Perineal desquamation: An early sign of the Kawasaki disease phenotype of MIS-C. Mazori DR; Derrick KM; Kapoor U; Haribhai M; Gist RE; Glick SA Pediatr Dermatol; 2021 Jan; 38(1):253-256. PubMed ID: 33222290 [TBL] [Abstract][Full Text] [Related]
12. Clinical and Laboratory Characteristics of Kawasaki Disease and COVID-19-Related Multisystem Inflammatory Syndrome in Children. Phi DL; Dao TL; To MM; Nguyen TB; Nguyen DC; Gautret P; Hoang VT J Korean Med Sci; 2023 Dec; 38(49):e410. PubMed ID: 38111281 [TBL] [Abstract][Full Text] [Related]
13. Pediatric Multisystemic Inflammatory Syndrome Temporarily associated with COVID-19: Clinical characteristics and management in a Pediatric Critical Care Unit. Yagnam R F; Izquierdo C G; Villena M R; González M C; Drago-T M Andes Pediatr; 2021 Jun; 92(3):395-405. PubMed ID: 34479246 [TBL] [Abstract][Full Text] [Related]
14. Differentiation of COVID-19-Associated Multisystem Inflammatory Syndrome From Kawasaki Disease With the Use of Cardiac Biomarkers. Fridman MD; Tsoukas P; Jeewa A; Yeung RSM; Gamulka BD; McCrindle BW Can J Cardiol; 2023 Jun; 39(6):815-823. PubMed ID: 36462758 [TBL] [Abstract][Full Text] [Related]
15. Multisystem inflammatory syndrome in children: A dysregulated autoimmune disorder following COVID-19. Lee PI; Hsueh PR J Microbiol Immunol Infect; 2023 Apr; 56(2):236-245. PubMed ID: 36720670 [TBL] [Abstract][Full Text] [Related]
17. Multisystem inflammatory syndrome in children rose and fell with the first wave of the COVID-19 pandemic in France. Carbajal R; Lorrot M; Levy Y; Grimprel E; Lecarpentier T; Heritier S; Faivre J; Schnuriger A; Parisot P; Blondiaux E; Loschi S; Rivière S; Guilbert J; Romain AS; Leger PL; Guedj R Acta Paediatr; 2021 Mar; 110(3):922-932. PubMed ID: 33190340 [TBL] [Abstract][Full Text] [Related]
18. Kawasaki disease (KD) and multisystem inflammatory syndrome in children (MIS-C) in a Middle Eastern patient cohort. Yavuz L; AlHamdani S; Alasrawi S; Wafadari D; Al-Fraihat A; Bebars MA; Nath J; Arango D; Pallavidino M; Jain R; Yavuz S; AlAwadhi M; Alkhayat A; Tayoun AA; Abuhammour WM Pediatr Rheumatol Online J; 2023 Jun; 21(1):64. PubMed ID: 37386568 [TBL] [Abstract][Full Text] [Related]
19. Atypical Kawasaki syndrome in COVID-19 infection: a case report of a multisystem inflammatory syndrome in a child (MIS-C). Sylverken J; Afari P; Martyn-Dickens C; Owusu SA; Oppong E; Akwetey F; Mensah E; Mahama H; Owusu SK; Antwi S Ghana Med J; 2021 Jun; 55(2 Suppl):64-67. PubMed ID: 35233117 [TBL] [Abstract][Full Text] [Related]
20. Delineating phenotypes of Kawasaki disease and SARS-CoV-2-related inflammatory multisystem syndrome: a French study and literature review. Cherqaoui B; Koné-Paut I; Yager H; Bourgeois FL; Piram M Rheumatology (Oxford); 2021 Oct; 60(10):4530-4537. PubMed ID: 33493353 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]